Form 4: Inspire Medical Systems' CTO, John Rondoni, Reports Stock Transactions

Chief Technology Officer of Inspire Medical Systems, John Rondoni, reports the disposition of shares to cover tax obligations and sales under a pre-arranged trading plan.

Summary

• John Rondoni, Chief Technology Officer of Inspire Medical Systems, reported transactions involving the company's common stock.
• On February 9, 2025, 315 shares were disposed of to cover tax obligations at a price of $182.15 per share.
• On February 11, 2025, 583 shares were sold at a price of $170.49 per share.
• Following these transactions, Rondoni directly owns 10,424 shares of Inspire Medical Systems.
• The sales were executed under a Rule 10b5-1 trading plan established on May 23, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions. It is common for executives to utilize Rule 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership.

Key Dates

Keywords

Form 4, Insider Trading, Stock Sale, Inspire Medical Systems, INSP, John Rondoni, Rule 10b5-1